Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 10489030)

Published in Neurology on September 11, 1999

Authors

R Martin1, R Dowler, F Gilliam, E Faught, R Morawetz, R Kuzniecky

Author Affiliations

1: UAB Epilepsy Center, Department of Neurology, University of Alabama at Birmingham School of Medicine, 35294-7216, USA.

Articles by these authors

Global assessment of nitrogen deposition effects on terrestrial plant diversity: a synthesis. Ecol Appl (2010) 4.61

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med (1998) 4.31

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology (1999) 2.72

Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology (1999) 2.61

Congenital porencephaly: MR features and relationship to hippocampal sclerosis. AJNR Am J Neuroradiol (1998) 2.08

Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology (1999) 2.07

Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology (1993) 1.90

Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy. Neurology (2005) 1.81

Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet (2001) 1.80

Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology (1999) 1.80

Bilateral parasagittal parietooccipital polymicrogyria and epilepsy. Ann Neurol (1997) 1.72

Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy. Ann Neurol (1997) 1.71

Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology (2005) 1.55

Significance of interictal temporal lobe delta activity for localization of the primary epileptogenic region. Neurology (1999) 1.49

Cerebral complications of angiography for transient ischemia and stroke: prediction of risk. Neurology (1979) 1.47

Characterization of mutations in the gene doublecortin in patients with double cortex syndrome. Ann Neurol (1999) 1.47

Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia (1997) 1.41

Cortical abnormalities in epilepsy revealed by local EEG synchrony. Neuroimage (2007) 1.37

Bilateral porencephalic defect and bilateral perisylvian polymicrogyria. Brain Dev (1991) 1.37

Acute psychotic symptoms induced by topiramate. Seizure (1999) 1.34

Hippocampal sclerosis in temporal lobe epilepsy demonstrated by magnetic resonance imaging. Ann Neurol (1991) 1.34

Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J Immunol (1997) 1.23

Improved health care resource utilization following video-EEG-confirmed diagnosis of nonepileptic psychogenic seizures. Seizure (1998) 1.16

Weight loss associated with vagus nerve stimulation. Neurology (2002) 1.14

Familial perisylvian polymicrogyria: a new familial syndrome of cortical maldevelopment. Ann Neurol (2000) 1.13

Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology (2002) 1.12

Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology (1998) 1.11

Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss? Arch Neurol (2001) 1.11

Magnetic resonance imaging in childhood intractable partial epilepsies: pathologic correlations. Neurology (1993) 1.09

Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res (2005) 1.09

Postmarketing experience with topiramate and cognition. Epilepsia (2001) 1.08

Predictive value of magnetic resonance imaging in temporal lobe epilepsy surgery. Arch Neurol (1993) 1.06

Subjective versus objective memory change after temporal lobe epilepsy surgery. Neurology (1999) 1.06

Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol (1995) 1.06

Epilepsy surgery outcome: comprehensive assessment in children. Neurology (1997) 1.05

The safety of rapid valproic acid infusion. Epilepsia (2000) 1.04

Adult myoclonic epilepsy: a distinct syndrome of idiopathic generalized epilepsy. Neurology (2000) 1.04

Cortical dysplasia in temporal lobe epilepsy: magnetic resonance imaging correlations. Ann Neurol (1991) 1.04

Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain (2008) 0.99

Topiramate increases cerebral GABA in healthy humans. Neurology (1998) 0.99

Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy. Neurology (1997) 0.97

Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology (1997) 0.96

Wisconsin Card Sorting performance in patients with temporal lobe epilepsy: clinical and neuroanatomical correlates. Epilepsia (2000) 0.96

Predictive value of 1H MRSI for outcome in temporal lobectomy. Neurology (1999) 0.96

Late-onset variant of Huntington's chorea. South Med J (1983) 0.95

Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG. Neurology (2003) 0.95

Individual memory change after anterior temporal lobectomy: a base rate analysis using regression-based outcome methodology. Epilepsia (1998) 0.94

Quantitative MRI in temporal lobe epilepsy: evidence for fornix atrophy. Neurology (1999) 0.94

Transient focal ischemia in subhuman primates. Neuronal injury as a function of local cerebral blood flow. J Neuropathol Exp Neurol (1983) 0.93

Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia (1994) 0.93

EEG spike detection with a Kohonen feature map. Ann Biomed Eng (2001) 0.93

Temporal lobe developmental malformations and epilepsy: dual pathology and bilateral hippocampal abnormalities. Neurology (1998) 0.92

Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease. Clin Genet (2012) 0.92

Altered brain sodium channel transcript levels in human epilepsy. Brain Res Mol Brain Res (1996) 0.91

Ambulatory EEG monitoring. J Clin Neurophysiol (1999) 0.91

Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome. Brain (1988) 0.90

Brainstem auditory evoked responses in brainstem infarction. Stroke (1985) 0.90

Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice. Springer Semin Immunopathol (1995) 0.90